Sponsored By

Vote

 


 

Vote ReNetX Bio

for Venture


ReNetX

 

Name

Erika R. Smith

 

Title

CEO

 

Company/Organization

ReNetX Bio

 

City/Town where Organization Located

New Haven

 

Company/organization description (<500 characters)

ReNetx Bio – a clinical stage company established to provide first-in-class therapeutics to treat damage to the central nervous system (CNS). The company's scientific founder, Dr. Stephen Strittmatter from Yale University, identified key factors that inhibit regrowth in the CNS. The company's novel protein therapeutic approach binds these inhibitors thereby enabling nerve fiber regrowth and increased synaptic plasticity for neural reconnection. ReNetX Bio has raised $25M, launched a Phase 1/2 clinical trial proof of concept trial and was granted "Fast Track Designation" from FDA.

 

Tell us about the milestones your venture accomplished in 2019, eg., key team members added, revenue level achieved, major sales made or endorsements received, successful exit, etc... (<500 characters)

Fast Track Designation, FDA approval and Launch of Clinical Trial Phase 1/2 study for spinal cord injury, License from major biotech

 

Stage: Does your venture generate revenue? YES or NO

No

 

What CT entrepreneur ecosystem resources (spaces, programs, events, schools, etc.) have helped you succeed? (<500 characters)

Yale, BioCT, Connecticut Innovations

 

What people are saying about ReNetX Bio...

 Changing lives through the REstoration of neural NETworks. Our mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma. ?The company was founded based on the innovative technology from Dr. Stephen Strittmatter's work at Yale University to improve neurologic function after CNS injury – creating a significant and completely unmet need estimated at >$5B annually. The technology allows neurons to regrow by eliminating factors that inhibit growth. This technology platform could help to restore function in patients who are suffering from spinal cord injuries, stroke, and glaucoma.  

Bill Kenney

 

 


 


 

Others in this category

 

Atelier Cho Thompson

 

Aureus Tech Inc

 

Bare Life

 

Byrd's Books

 

Conscious Capital Wealth Management

 

Convexity Scientific

 

Cybrexa

 

DICOM Director

 

Encapsulate

 

Engagement Solutions

 

Enviro Power

 

Everything Bags inc

 

FinTron Invest

 

Framework Television

 

Geyser Remediation

 

Goat Boy Soaps

 

Green Check Verified

 

Green Home Solutions

 

Healthy PlanEat

 

Higher Education Literacy Professionals

 

Ivorleaf

 

Jubian

 

Karching

 

Lactation Innovations

 

Land Maverick

 

Levo International

 

Litchfield Distillery

 

Lolleez

 

Nami Therapeutics

 

New London Main Street

 

Noteworthy Chocolates

 

Oma's Pride

 

Paul's Custom Pet Food LLC

 

Phoenix Tailings

 

QRfertile

 

Rafael Goldstein and Tyler Lederer-Plaskett

 

Raise Green

 

Ricker Duval

 

Roast Me

 

Rope Safe

 

SaniBrands, Inc.

 

Savkar

 

Silver Fern Healthcare

 

SnapSeat

 

Sound Affects

 

Sourcery

 

SphereGen

 

Stemify.AI

 

The Feel Good Lab

 

The Scoop Glastonbury

 

Therapeutic Bandage Products

 

Traveling Chic Boutique

 

Valisure

 

Villarina's Pasta Shop

 

 

Escort Girl